| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/31/2011 | US20110077277 Organic compounds |
| 03/31/2011 | US20110077276 Methods and Compositions for Reduction of Side Effects of Therapeutic Treatments |
| 03/31/2011 | US20110077275 Antioxidant compositions for soft oral tissue and methods of formulation and use thereof |
| 03/31/2011 | US20110077274 Substituted-aryl-2-phenylethyl-1h-imidazole compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
| 03/31/2011 | US20110077273 New benzimidazole derivatives |
| 03/31/2011 | US20110077272 Pulmonary formulations of triptans |
| 03/31/2011 | US20110077271 Process for the Preparation of Donepezil Hydrochloride |
| 03/31/2011 | US20110077270 Compositions and Methods for Treating Ocular Inflammation with Lower Risk of Increased Intraocular Pressure |
| 03/31/2011 | US20110077269 Derivatives for modulation of ion channels |
| 03/31/2011 | US20110077268 Kinase inhibitors and methods of use |
| 03/31/2011 | US20110077267 Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor or erythropoietin production-inducing agent |
| 03/31/2011 | US20110077266 Diamine Derivatives |
| 03/31/2011 | US20110077265 Inhibitors of iap |
| 03/31/2011 | US20110077264 Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics |
| 03/31/2011 | US20110077263 Methods and Compositions of Toll-Like Receptor (TLR) Agonists |
| 03/31/2011 | US20110077262 Novel spirochromanone carboxylic acids |
| 03/31/2011 | US20110077261 Prevention of hiv-infection |
| 03/31/2011 | US20110077260 Methods, compositions, and kits for organ protection during systemic anticancer therapy |
| 03/31/2011 | US20110077259 Compositions and methods for treating and preventing dermatoses |
| 03/31/2011 | US20110077258 Treatment of malaria |
| 03/31/2011 | US20110077257 Substituted dihydro, trihydro and tetrahydro cycloalkyloxazolopyrimidinones, preparation and use thereof |
| 03/31/2011 | US20110077256 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 03/31/2011 | US20110077255 Substituted xanthine derivatives |
| 03/31/2011 | US20110077254 Compounds |
| 03/31/2011 | US20110077253 Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
| 03/31/2011 | US20110077252 Pyridyl derivatives, their preparation and use |
| 03/31/2011 | US20110077251 Novel 17 beta lupane derivatives |
| 03/31/2011 | US20110077250 Compounds for modulating rna binding proteins and uses therefor |
| 03/31/2011 | US20110077249 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives |
| 03/31/2011 | US20110077248 Imidazopyridine and related analogs as sirtuin modulators |
| 03/31/2011 | US20110077247 Class of histone deacetylase inhibitors |
| 03/31/2011 | US20110077246 Bicyclic heterocyclic compounds pharmaceutical compositions containing these compounds, their use and process for preparing the same |
| 03/31/2011 | US20110077245 Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
| 03/31/2011 | US20110077244 Novel thiophenediamine derivative having urea structure |
| 03/31/2011 | US20110077243 Triazolopyridine Compounds Useful As Kinase Inhibitors |
| 03/31/2011 | US20110077242 Diaminopyrimidines as p2x3 and p2x2/3 antagonists |
| 03/31/2011 | US20110077241 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
| 03/31/2011 | US20110077240 Inhibitors of protein tyrosine kinase activity |
| 03/31/2011 | US20110077239 Glycine receptor agonists for the treatment of phantom phenomena |
| 03/31/2011 | US20110077238 Methods and compositions for deterring abuse |
| 03/31/2011 | US20110077237 Kinase inhibitors |
| 03/31/2011 | US20110077236 New carboxylic acid amides, the preparation thereof and their use as medicaments |
| 03/31/2011 | US20110077235 Apoptosis signal-regulating kinase 1 inhibitors |
| 03/31/2011 | US20110077234 Urea Glucokinase Activators |
| 03/31/2011 | US20110077233 C-Met Modulators and Method of Use |
| 03/31/2011 | US20110077232 Compositions comprising atorvastatin 4-(nitrooxy) butyl ester and a hypolipidemic drug |
| 03/31/2011 | US20110077231 Compounds |
| 03/31/2011 | US20110077230 Copper organocomplexes, use thereof as antitumor means and for protecting healthy tissue from ionizing radiation |
| 03/31/2011 | US20110077229 Steroid Containing Drug Delivery Systems |
| 03/31/2011 | US20110077228 Novel c-21-keto lupane derivatives preparation and use thereof |
| 03/31/2011 | US20110077227 Novel lupane derivatives |
| 03/31/2011 | US20110077226 Methods for Inhibiting the Development of Huntington's Disease |
| 03/31/2011 | US20110077225 4-Substituted Tetracyclines and Methods of Use Thereof |
| 03/31/2011 | US20110077224 Linoleic phospholipids and uses thereof for inhibiting inflammatory and neurodegenerative processes |
| 03/31/2011 | US20110077222 Sustained-Release Opiate and Opiate Derivative Compositions |
| 03/31/2011 | US20110077221 Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof |
| 03/31/2011 | US20110077220 4-oxo,1-4-dihydroquinoline m1 receptor positive allosteric modulators |
| 03/31/2011 | US20110077219 Ophthalmic pharmaceutical compositions based on amino acids and sodium hyaluronate |
| 03/31/2011 | US20110077218 Wound-healing pharmaceutical compositions in the form of a sterile powder based on amino acids and sodium hyaluronate |
| 03/31/2011 | US20110077217 Selectively depolymerized galactomannan polysaccharide |
| 03/31/2011 | US20110077216 Compositions and methods for the treatment of atherosclerosis and other related diseases |
| 03/31/2011 | US20110077215 DNA Methylation As A Target For Diagnosis And Treatment Of Chronic Lymphocytic Leukema (CLL) |
| 03/31/2011 | US20110077214 Method for treating hyponatremia employing an sglt2 inhibitor and composition containing same |
| 03/31/2011 | US20110077213 Method for treating and preventing kidney stones employing an sglt2 inhibitor and composition containing same |
| 03/31/2011 | US20110077212 Therapeutic uses of sglt2 inhibitors |
| 03/31/2011 | US20110077208 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 03/31/2011 | US20110077206 Use of hnf4alpha for treatment of human malignant solid tumors through induction-differentiation therapy |
| 03/31/2011 | US20110077203 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use |
| 03/31/2011 | US20110077200 Combination therapy using low-dose doxepin for the improvement of sleep |
| 03/31/2011 | US20110077198 Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition |
| 03/31/2011 | US20110077194 Method for Treating or Preventing a Functional Vitamin B12 Deficiency in an Individual and to Medical Compositions for Use in Said Method |
| 03/31/2011 | US20110077193 Artemisinin Derivatives with Natural Amino Acids, Peptides, and Amino Sugars for the Treatment of Infection and Topical Condition in Mammals |
| 03/31/2011 | US20110077189 Composition for stimulating natural killer cell activity |
| 03/31/2011 | US20110076766 Cytostatic Drug Composition |
| 03/31/2011 | US20110076765 Method for increasing the activity of lysosomal enzymes |
| 03/31/2011 | US20110076343 Multiple Myeloma Treatments |
| 03/31/2011 | US20110076339 Colon Cleansing Method and Kit |
| 03/31/2011 | US20110076336 Dry powder pharmaceutical compositions for pulmonary administration, and methods of manufacturing thereof |
| 03/31/2011 | US20110076335 Novel lipid formulations for delivery of therapeutic agents to solid tumors |
| 03/31/2011 | US20110076334 Methods and compositions for treatment of raynaud's phenomenon |
| 03/31/2011 | US20110076332 Dextran-chitosan based in-situ gelling hydrogels for biomedical applications |
| 03/31/2011 | US20110076328 Compositions for the treatment of hair loss |
| 03/31/2011 | US20110076326 Modified protein excipient for delayed-release tablet |
| 03/31/2011 | US20110076325 Abuse resistant drugs, method of use and method of making |
| 03/31/2011 | US20110076324 Use of Histamine H4 antagonist for the treatment of post-operative adhesions |
| 03/31/2011 | US20110076322 Amphoteric liposomes |
| 03/31/2011 | US20110076321 Self-adhesive polymer matrix containing sea algae extract |
| 03/31/2011 | US20110076319 Bioresorbable metal stent with controlled resorption |
| 03/31/2011 | US20110076318 Retinoid-containing sustained release intraocular implants and related matters |
| 03/31/2011 | US20110076315 Grafts and Stents Having Inorganic Bio-Compatible Calcium Salt |
| 03/31/2011 | US20110076314 Hydrophobic polysaccharides with silyl ether linkages having enhanced degradation and medical articles made therefrom |
| 03/31/2011 | US20110076308 Micelle encapsulation of therapeutic agents |
| 03/31/2011 | US20110076307 Polycationic gene carriers formed of endogenous amino group-bearing monomers |
| 03/31/2011 | US20110076306 Arabinogalactan for enhancing the adaptive immune response |
| 03/31/2011 | US20110076299 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 03/31/2011 | US20110076296 TLR3 Agonist Compositions |
| 03/31/2011 | US20110076295 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 03/31/2011 | US20110076293 Triptolide derivatives for modulation of apoptosis and immunosuppression |
| 03/31/2011 | US20110076292 Benzoxazepin pi3k inhibitor compounds and methods of use |
| 03/31/2011 | US20110076291 Benzoxepin pi3k inhibitor compounds and methods of use |